Nachrichten zur Veru Inc. Aktie

Veru: The Russian/Ukraine Conflict May Pose Challenges

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

CNBC Pro Talks: Veteran money manager Dan Veru breaks down his top value investing ideas

Palisade Capital CIO joined CNBC Pro on Wednesday to discuss investing. based on valuations....…

Veru updates Phase 1b/2 data for sabizabulin in prostate cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru to further advance late-stage trial for COVID-19 therapy after data analysis

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Reports that Independent Data Monitoring Committee for the Phase 3 Sabizabulin COVID-19 Clinical Study Recommends Continuing Study as Planned

--Planned Conditional Statistical Power Analysis was Conducted—...…

Veru Inc. (VERU) CEO Mitchell Steiner on Q1 2022 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q VERU INC. For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Inc. (VERU) Reports Q1 Loss, Misses Revenue Estimates

Veru Inc. (VERU) delivered earnings and revenue surprises of 27.27% and 17.99%, respectively, for the quarter ended December 2021. Do…

Form 8-K VERU INC. For: Feb 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru GAAP EPS of -$0.08 beats by $0.02, revenue of $14.14M misses by $3.16M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru FQ1 2022 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Can Veru Inc. (VERU) Climb 344% to Reach the Level Wall Street Analysts Expect?

The consensus price target hints at a 343.6% upside potential for Veru Inc. (VERU). While empirical research shows that this…

Dan Veru of Palisades: Be careful not to overpay for anything in this market

Dan Veru, Co-Chairman and CIO of Palisades Capital Management, joins Worldwide Exchange to discuss his market outlook and where he's…

Earnings Preview: Veru Inc. (VERU) Q1 Earnings Expected to Decline

Veru Inc. (VERU) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

Veru Enters into Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to Evaluate Enobosarm in Combination with Verzenio® in Phase 3 ENABLAR-2 Trial

-- Phase 3 ENABLAR-2 Clinical Trial for 2nd Line Treatment of AR+ER+HER2- Metastatic Breast Cancer Expected to Commence During First Quarter…

Veru rises 4% on FDA fast track designation for sabizabulin to treat COVID-19

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Gets Fast Track Designation for Sabizabulin

Veru Gets Fast Track Designation for Sabizabulin...…

Veru Announces FDA Grant of Fast Track Designation for Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome

-- Phase 3 Sabizabulin COVID-19 Clinical Study for Treatment of Hospitalized Moderate to Severe COVID-19 Patients at High Risk for…

Veru to Report Fiscal 2022 First-Quarter Financial Results, Host Conference Call on February 9th

MIAMI, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…

Why Veru Stock Triumphed on Tuesday

The company wins Fast Track designation for a top pipeline program....…

Veru rebounds on late recognition of Fast Track tag for breast cancer drug

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Shares Rise 14%, Rebound From Mondays 52-Week Low

Veru Shares Rise 14%, Rebound From Monday's 52-Week Low...…

Why Jim Cramer Likes Grab Holdings

On CNBCs "Mad Money Lightning Round," Jim Cramer said Veru Inc. (NASDAQ: VERU)s Enobosarm was granted fast track designation…

Veru Shares Hit 52-Week Low After Fast-Track Designation for Enobosarm

Veru Shares Hit 52-Week Low After Fast-Track Designation for Enobosarm...…

Veru up 7% on FDA Fast Track tag for enobosarm for metastatic breast cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Gets Fast-Track Designation for Breast-Cancer Treatment

Veru Gets Fast-Track Designation for Breast-Cancer Treatment...…

Veru to Present Corporate Update at the H.C. Wainwright BioConnect Conference on January 10-13, 2022

MIAMI, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…

Veru: Believe the markets are going to perform really well in 2022

Dan Veru of Palisade Capital Management discusses why believes stocks are in line for more gains this year, and why…

Veru Shares Up After FDA Approves Entadfi in Benign Prostatic Hyperplasia

Veru Shares Up After FDA Approves Entadfi in Benign Prostatic Hyperplasia...…

Veru Announces FDA Approval of ENTADFI, a New Treatment for Benign Prostatic Hyperplasia

--ENTADFI (Finasteride and Tadalafil) Capsules to Treat Benign Prostatic Hyperplasia-- --Commercialization Will Start Early Calendar Year 2022--...…

Veru, Inc. (VERU) CEO Mitchell Steiner on Q4 2021 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-K VERU INC. For: Sep 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru: Q4 Earnings Insights

Veru (NASDAQ:VERU) reported its Q4 earnings results on Thursday, December 2, 2021 at 06:30 AM. Heres what investors need to know…

Veru Reports Record Fiscal 2021 Full-Year Financial Results

--FY21 Net Revenues Increase 44% to $61 Million and Gross Profit Increases 56% to $48 Million, Achieving New Historical Highs--…

Veru Q4 2021 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Earnings Outlook For Veru

Veru (NASDAQ:VERU) is set to give its latest quarterly earnings report on Thursday, 2021-12-02. Heres what investors need to know…

Analysts Estimate Veru Inc. (VERU) to Report a Decline in Earnings: What to Look Out for

Veru Inc. (VERU) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

Veru to Report Fiscal 2021 Fourth-Quarter, Full-Year Financial Results, Host Conference Call on December 2nd

MIAMI, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…

Veru Ranked as one of the Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500

-- Veru is a Late-Stage Clinical Development Biopharmaceutical Company Developing Drugs for the Treatment of Breast Cancer, Prostate Cancer, and…

Alibaba: Darum ist Jack Ma wirklich in Ungnade gefallen

Mit der Absage des Ant-Group-Börsengangs begann Ende 2020 der Kurssturz bei Alibaba. Alibaba- und Ant-Gründer Jack Ma zog sich daraufhin…

Veru Enrolls First Patient in International Phase 3 ARTEST Clinical Trial of Enobosarm in Metastatic Breast Cancer

-- Enobosarm is a novel targeted hormone drug to be evaluated in the 3rd line treatment of androgen receptor positive…

Veru provides additional phase 1b/2 data on prostate cancer candidate sabizabulin

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Announces Positive Updated Data from Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress

MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…